Inside Home Trial Support: Safety, Logistics, And The Patient Experience
Go behind the scenes with MRN’s CEO, Stuart Redding, to learn how MRN is transforming clinical trials by bringing them directly to patients—wherever they live, work, or play. By administering investigational medicinal products (IMPs) in the home and collecting safety lab samples on-site, MRN enhances patient convenience and accessibility. This patient-centric approach breaks down barriers that often prevent participation in clinical research, increasing inclusivity and improving real-world data accuracy. MRN’s capabilities span all trial phases and medical indications, providing seamless support throughout the clinical research process. Under Stuart Redding’s leadership, MRN is redefining how clinical trials are conducted, prioritizing patient access and experience. This innovative model not only benefits patients but also helps sponsors achieve more representative populations and better trial outcomes. Explore how MRN’s comprehensive, flexible solutions are setting new standards for bringing clinical research closer to the communities it serves.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.